Tokyo - Delayed Quote • JPY
Compare
At close: 3:15 PM GMT+9
Line
Candle
Baseline
Mountain
Bar
Loading Chart for 4543.T
9/21 12:03 PM
DELL
Date | |
Close | |
Open | |
High | |
Low | |
Volume |
- Previous Close
2,574.50 - Open
2,550.00 - Bid --
- Ask --
- Day's Range
2,542.00 - 2,600.50 - 52 Week Range
1,856.00 - 3,014.50 - Volume
2,931,400 - Avg. Volume
3,368,731 - Market Cap (intraday)
3.845T - Beta (5Y Monthly) 0.47
- PE Ratio (TTM)
36.18 - EPS (TTM)
71.57 - Earnings Date Aug 7, 2024 - Aug 12, 2024
- Forward Dividend & Yield 26.00 (1.01%)
- Ex-Dividend Date Sep 27, 2024
- 1y Target Est
3,092.50
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.
--
Full Time Employees
March 31
Fiscal Year Ends
Healthcare
Sector
Industry
More about Terumo Corporation
Recent News: 4543.T
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview: 4543.T
Trailing total returns as of 6/18/2024, which may include dividends or other distributions. Benchmark is Nikkei 225
YTD Return
4543.T
12.49%
Nikkei 225
14.99%
1-Year Return
4543.T
13.03%
Nikkei 225
14.17%
3-Year Return
4543.T
17.09%
Nikkei 225
32.86%
5-Year Return
4543.T
71.45%
Nikkei 225
83.49%
Compare To: 4543.T
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
2,589.50
+0.58%
Mkt Cap JPY 3.845T
Industry Medical Instruments & Supplies
2,516.00
-0.51%
Mkt Cap JPY 1.569T
Industry Medical Instruments & Supplies
1,219.50
+0.66%
Mkt Cap JPY 198.896B
Industry Medical Instruments & Supplies
2,637.00
+1.42%
Mkt Cap JPY 3.074T
Industry Medical Instruments & Supplies
18,355.00
+1.52%
Mkt Cap JPY 6.424T
Industry Medical Instruments & Supplies
4.350
-0.91%
Mkt Cap HKD 4.156B
Industry Medical Instruments & Supplies
177.35
+3.11%
Mkt Cap EUR 17.932B
Industry Medical Instruments & Supplies
19.96
-1.43%
Mkt Cap 919.533M
Industry Medical Instruments & Supplies
206.80
+0.29%
Mkt Cap EUR 94.21B
Industry Medical Instruments & Supplies
322.07
-4.17%
Mkt Cap 23.577B
Industry Medical Instruments & Supplies
212.27
+0.91%
Mkt Cap 31.184B
Industry Medical Instruments & Supplies
Statistics: 4543.T
Valuation Measures
As of 6/17/2024
Market Cap
3.82T
Enterprise Value
3.82T
Trailing P/E
36.02
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.16
Price/Book (mrq)
2.88
Enterprise Value/Revenue
4.15
Enterprise Value/EBITDA
17.35
Financial Highlights
Profitability and Income Statement
Profit Margin
11.54%
Return on Assets (ttm)
5.21%
Return on Equity (ttm)
8.73%
Revenue (ttm)
921.86B
Net Income Avi to Common (ttm)
106.37B
Diluted EPS (ttm)
71.57
Balance Sheet and Cash Flow
Total Cash (mrq)
204.88B
Total Debt/Equity (mrq)
17.47%
Levered Free Cash Flow (ttm)
8.1B
Research Analysis: 4543.T
Company Insights: 4543.T
Research Reports: 4543.T
People Also Watch
7733.T Olympus Corporation
2,637.00
+1.42%
1925.T Daiwa House Industry Co., Ltd.
3,993.00
-0.18%
4519.T Chugai Pharmaceutical Co., Ltd.
5,049.00
+2.17%
6301.T Komatsu Ltd.
4,450.00
+1.62%
4503.T Astellas Pharma Inc.
1,505.00
-0.30%
9433.T KDDI Corporation
4,177.00
+0.05%
4568.T Daiichi Sankyo Company, Limited
5,311.00
-1.65%
3402.T Toray Industries, Inc.
741.50
+1.33%
6981.T Murata Manufacturing Co., Ltd.
3,310.00
+2.22%
5201.T AGC Inc.
5,220.00
+0.31%
4507.T Shionogi & Co., Ltd.
6,097.00
-0.81%
7741.T HOYA Corporation
18,355.00
+1.52%
4523.T Eisai Co., Ltd.
6,295.00
-1.25%
5713.T Sumitomo Metal Mining Co., Ltd.
4,730.00
+0.90%
9005.T Tokyu Corporation
1,763.50
+0.57%
4452.T Kao Corporation
6,768.00
+0.18%